𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain

✍ Scribed by Helen Hays; Neil Hagen; Michael Thirlwell; H. Dhaliwal; Najib Babul; Zoltan Harsanyi; Andrew C. Darke


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
933 KB
Volume
74
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Comparative clinical efficacy and safety
✍ Neil A. Hagen; Najib Babul πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 210 KB πŸ‘ 2 views

Fredphone, each given every 12 hours for 7 days. Pain intensity, nausea, and sedation erick, Pickering, Ontario, Canada. were assessed by patients four times daily, and breakthrough analgesia was recorded. ## RESULTS. Thirty-one patients completed the study (18 women, 13 men; mean age, 56 { 3 ye

Controlled-release morphine tablets in p
✍ Carol A. Warfield πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 143 KB πŸ‘ 2 views

## Background: Controlled-release (cr) morphine tablets have become routine therapy in the management of cancer pain. compared with immediate-release (ir) morphine, this formulation provides the benefit of dosing every 12 hours. ## Methods: This study reviewed the 10 published, well controlled, r